Insider Transactions in Q2 2021 at Medtronic PLC (MDT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,500
-12.31%
|
$1,437,500
$125.29 P/Share
|
|
Jun 28
2021
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+10.96%
|
$632,500
$55.32 P/Share
|
|
Jun 22
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
714
+22.02%
|
-
|
|
Jun 22
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
714
-0.28%
|
-
|
|
Jun 21
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct |
115
-0.53%
|
$14,145
$123.5 P/Share
|
|
Jun 18
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
938
-4.14%
|
$115,374
$123.23 P/Share
|
|
Jun 18
2021
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
1,168
+4.9%
|
$86,432
$74.84 P/Share
|
|
Jun 15
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
605
-0.7%
|
$75,020
$124.47 P/Share
|
|
Jun 01
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct |
2,473
-10.32%
|
$316,544
$128.07 P/Share
|
|
May 28
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
7,355
-23.49%
|
$926,730
$126.59 P/Share
|
|
May 28
2021
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
12,300
+28.2%
|
$578,100
$47.0 P/Share
|
|
May 28
2021
|
John R Liddicoat EVP & President of Americas |
SELL
Open market or private sale
|
Direct |
34,656
-44.89%
|
$4,366,656
$126.65 P/Share
|
|
May 28
2021
|
John R Liddicoat EVP & President of Americas |
BUY
Exercise of conversion of derivative security
|
Direct |
34,656
+10.63%
|
$2,876,448
$83.03 P/Share
|
|
May 03
2021
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+1.28%
|
-
|
|
May 03
2021
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+3.89%
|
-
|
|
May 03
2021
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+9.09%
|
-
|
|
May 03
2021
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+30.89%
|
-
|
|
May 03
2021
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+33.22%
|
-
|
|
May 03
2021
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+5.77%
|
-
|
|
May 03
2021
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+2.25%
|
-
|
|
May 03
2021
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+50.0%
|
-
|
|
May 03
2021
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+11.41%
|
-
|
|
May 03
2021
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+1.9%
|
-
|
|
May 03
2021
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+3.63%
|
-
|
|
Apr 27
2021
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-1.23%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-0.63%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-4.51%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-0.75%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-24.01%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Andrea Jo Goldsmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-20.51%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-3.42%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-1.33%
|
$54,954
$129.97 P/Share
|
|
Apr 27
2021
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-0.42%
|
$54,954
$129.97 P/Share
|
|
Apr 05
2021
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,712
-6.53%
|
$1,382,016
$118.83 P/Share
|
|
Apr 05
2021
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,712
+6.01%
|
$562,176
$48.46 P/Share
|